Toll Brothers EBIT

The latest EBIT for TOL is $1.5B as of July 2026. That compares with $1.8B in the prior-year period — down 14.6% year over year. That is below the Healthcare sector average of $23B. Investors often review this figure alongside Toll Brothers's historical trend and sector peers before judging valuation or financial health.

Over the past year, TOL's EBIT moved from $1.8B to $1.5B — a 14.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Toll Brothers's operating scale or balance-sheet position.

Against Healthcare companies, TOL currently prints $1.5B for EBIT, while the sector average sits near $23B. That is roughly 93.4% below the sector mean. Large gaps often invite a closer look at Toll Brothers's growth, margins, and balance sheet.

A EBIT figure of $1.5B for TOL is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $23B. Explore the charts below for those layers of context.

After noting TOL's EBIT ($1.5B), review year-over-year change from $1.8B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.